Wuyi International Pharmaceutical Company Ltd. provided consolidated earnings guidance for the full year ended December 31, 2015. The Group is expected to record a turnaround of its results in 2015 by recording a significant increase in the consolidated net profit for the year ended December 31, 2015 as compared to the net loss for the year ended December 31, 2014. Unaudited overall revenue for the year ended December 31, 2015 increased slightly by approximately 1.1% to approximately RMB 555.7 million compared to approximately RMB 549.6 million a year ago.

The significant improvement in the financial results of the Group is mainly due to the following reasons: the company's interim results for the six-month period ended June 30, 2015, the company completed the disposal of the land use rights and the property, plant and equipment held by Fuzhou Sanai Pharmaceutical Co. Ltd., in the first half of 2015. The net gain on disposal of such land use rights and the property, plant and equipment was approximately RMB 35.0 million; and the management anticipates that impairment losses on the non-current assets will be absent or such losses would significantly decrease for the year ended December 31, 2015 (for the year ended December 31, 2014: the impairment losses related to property, plant and equipment and land use rights of the Group amounted to approximately RMB 44.8 million (audited) and RMB 3.2 million (audited) respectively).